Outline
Comptes Rendus

Medical sciences/Sciences médicales
Nutrition and sickle cell disease
Comptes Rendus. Biologies, Volume 336 (2013) no. 3, pp. 159-163.

Abstract

A common observation in sickle cell disease is growth retardation, in particular, wasting. Wasting is associated with increased hospitalization and possibly poorer clinical outcomes. Therefore understanding the mechanism of wasting is crucial and reducing the degree of wasting by improving the nutritional status, holds the potential for modifying the course of the disease.

Metadata
Published online:
DOI: 10.1016/j.crvi.2012.09.007
Keywords: Sickle Cell anemia, Wasting, Appetite, Hypermetabolism

Marvin Reid 1

1 University of the West Indies, Mona, Tropical Medicine Research Institute, Sickle Cell Unit, Kingston, Jamaica
@article{CRBIOL_2013__336_3_159_0,
     author = {Marvin Reid},
     title = {Nutrition and sickle cell disease},
     journal = {Comptes Rendus. Biologies},
     pages = {159--163},
     publisher = {Elsevier},
     volume = {336},
     number = {3},
     year = {2013},
     doi = {10.1016/j.crvi.2012.09.007},
     language = {en},
}
TY  - JOUR
AU  - Marvin Reid
TI  - Nutrition and sickle cell disease
JO  - Comptes Rendus. Biologies
PY  - 2013
SP  - 159
EP  - 163
VL  - 336
IS  - 3
PB  - Elsevier
DO  - 10.1016/j.crvi.2012.09.007
LA  - en
ID  - CRBIOL_2013__336_3_159_0
ER  - 
%0 Journal Article
%A Marvin Reid
%T Nutrition and sickle cell disease
%J Comptes Rendus. Biologies
%D 2013
%P 159-163
%V 336
%N 3
%I Elsevier
%R 10.1016/j.crvi.2012.09.007
%G en
%F CRBIOL_2013__336_3_159_0
Marvin Reid. Nutrition and sickle cell disease. Comptes Rendus. Biologies, Volume 336 (2013) no. 3, pp. 159-163. doi : 10.1016/j.crvi.2012.09.007. https://comptes-rendus.academie-sciences.fr/biologies/articles/10.1016/j.crvi.2012.09.007/

Original version of the full text

1 Introduction

Sickle cell disease (SCD) refers to a group of autosomal recessive disorders in which the inheritance of the haemoglobin S allele in a homozygous state (sickle cell anaemia [SCA]), or in combination with one other variant allele, most commonly haemoglobin C, or with a β-thalassaemic allele results in the presence of greater than 50% haemoglobin S concentration in blood. This group of chronic diseases poses significant public health challenges in Jamaica and many Caribbean countries.

A common observation in SCA is growth retardation, in particular, wasting. The poor growth results from a combination of relative hypophagia and increased metabolic demands driven by increased whole body protein turnover, glucose and lipid fluxes and resting metabolic rate. Sickle cell related complications exacerbate the metabolic demand and in addition, imposes specific ones, e.g., arginine for nitric oxide production and cysteine.

The subsequent metabolic adaptation to mismatch between energy intake and demand is complex and involves changes in body composition manifested as wasting and a repartitioning of the components of energy expenditure. The importance of understanding the mechanism of wasting resides in the observation that wasting, a marker of negative energy balance is associated with increased hospitalization and possibly poorer clinical outcomes.

2 Background

Human nutrition is the science that deals with the interaction between metabolic demand and dietary intake. There are many factors that modulate this interaction including socioeconomic, genetic, disease factors [1] and more recently “metabolic set” [2]. Current nutritional doctrine posits that metabolic demand drives dietary intake [3]. The metabolic demand consists of basal demand which is defined as the energy expended to maintain homeostasis at rest after a 12 h fast in a thermoneutral environment and a variable component which comprises energy associated with thermic effect of food, growth and activity [4,5].

Nutritional research in sickle cell anaemia (SCA) has focused on relating clinical features of sickle cell anaemia to nutritional abnormalities as well as nutritional strategies to modulate or improve clinical manifestations. The focus of this article will be on the growth retardation, in particular, the wasting observed in SCA and its nutritional correlates.

3 Pathophysiology of sickle cell anaemia

The nutritional and metabolic context of homozygous S sickle cell disease (sickle cell anaemia) is determined by pathophysiologic processes initiated by the high intra-erythrocytic concentration of HbS and includes haemolysis, compensatory haematopoeisis, vaso-occlusion, reperfusion injury and inflammation [6]. The initiating event is polymerization of HbS, which promotes pathological changes in erythrocytes that in turn cause vascular occlusion. Several metabolic and physiological mechanisms are activated in response to the pathophysiological cascade [7]. In response to activation and increased turnover in these systems, whole body protein turnover [8–10], glucose and lipid fluxes [11] and resting metabolic rate are all increased [9,10,12–16]. Sickle cell related complications will exacerbate these metabolic demands and in addition, place specific ones, e.g., for arginine – immediate precursor of nitric oxide [17] and cysteine [8]. This increase in the metabolic demand has to be met from the diet in order to maintain body cell mass.

Although the birth weight of newborns with SCA is not different from AA controls [18], numerous studies [19,20] from the Caribbean [21], Latin America [22], the USA [23] and Africa [24] have reported growth deficits beginning in childhood. For example in the Jamaican Sickle Cell Cohort Study (JSCCS), a longitudinal observational study of sickle cell disease and its clinical manifestations, children with SCA had significantly lower weight and height compared with the NCHS growth reference standard from as early as 3 months of age [25] and significantly lower weight and height velocity compared with age matched HbAA controls from 2 years of age [26]. The deficit in weight persists through adolescence and adulthood and at age 17 years, the mean weight deficit was ∼ 10 kg.

Wasting or under nutrition has long been recognized as a marker of impaired survival in free living individuals with primary malnutrition [27] as well as in chronic diseases such as cystic fibrosis [28], congestive heart failure, cancer cachexia and HIV [29]. In SCA, the reported predictors of morbidity were an episode of dactylitis prior to age 1, a haemoglobin < 7 g/dL and leukocytosis [30]. However, the clinical utility of these predictors is unclear [31]. Notwithstanding, the emphasis on the role of clinical and haematological factors as predictors of morbidity has distracted attention from the role that sup-optimal nutrition may have on the natural history of SCA. For example, recently Cox et al. have reported that wasting was related to increased frequency of hospitalization but not to mortality in non-birth cohort of African children [32].

4 Why are subjects with sickle cell anaemia wasted?

4.1 Energy intake

The long-term gain or loss of body weight indicates positive or negative energy balance, respectively. Therefore, in the presence of wasting relative to AA controls, two questions arise:

  • • is energy intake lower in SCA?
  • • is energy expenditure greater in SCA?

We have measured energy intake in a random sample of 50 adults with SCA (29 males and 21 females), aged 19–25 years using a 24 h dietary recall and a three-day diet diary. The energy intake in this sample was 11.6 ± 3.9 MJ/d, (males) and 8.8 ± 1.6 MJ/d (females) whilst the protein intakes were 88.3 ± 31.2 g/d and 64.8 ± 16.4 g/d for males and females respectively (unpublished). These intakes in absolute terms tended to be lower than the intake of energy (12.2 ± 4.3 MJ/d, males; 9.7 ± 3.9 MJ/d, females) and protein (93.9 ± 36.7 g/d, males; 75.7 ± 35.9 females) among Jamaican adults [33], but when weight normalized are actually comparable. Similarly Singhal et al. [16] and others [13,34,35] have reported that energy and protein intake in children were not different compared with age matched controls. Most estimates of energy intake in SCA have been performed in the steady state, but the natural history of SCA is characterized by frequent acute crises [36] accompanied by anorexia and/or reduced physical activity. Energy intake is likely to fall and energy expenditure to rise in a crisis, producing a negative energy balance. The presence of wasting on the background of high REE implies that energy intake is inappropriately low at steady state in SCA. This relative hypophagia may be due to suppression of appetite from early in life. This is supported by the results of the study by Heyman et al. [37]. In this study, nutritional supplementation with increased energy and protein by the nasogastric route which effectively bypassed the normal appetite regulatory mechanism, produced a rapid and sustained increase in growth rate, associated with striking reductions in pain crises and infections in children. However, the available evidence suggests that application of this technique as a regular component of clinical care is not advisable as the administration of inappropriate amounts of energy and protein is associated with increased risk of the overfeeding syndrome and death [38].

The relative hypophagia of SCA might be produced by inflammatory mediators e.g. IL6. The control of appetite involves the interaction of short-term and long-term regulatory systems [39]. The short-term regulation of appetite is thought to mediated by overlapping and redundant neurohumoral systems [40]. For example, changes in circulating glucose concentrations will elicit meal initiation and termination by regulating activity of specific hypothalamic neurons that respond to glucose [41]. Other nutrients (e.g., amino acids and fatty acids), gastrointestinal peptide hormones, most notably ghrelin, PYY and cholecystokinin, as well as autonomic afferents signaling gastric distension are also involved in short-term regulation of food intake. The set points of these neurohumoral systems vary among individuals leading to significant meal-to-meal variation in intake and thus short-term gain or loss of weight. They are also integrated with longer-term humoral regulators of appetite such as insulin, and leptin, a protein hormone produced mainly by adipocytes, and possibly also other adipocytokines to maintain energy homeostasis. Insulin and leptin, are transported into the brain where they inhibit the secretion of the orexigenic hypothalamic neuropeptide Y and agouti-related peptide (AGRP) which stimulate food intake and decrease energy expenditure thereby regulating feeding behaviour and body weight [40]. Circulating insulin and leptin concentrations are proportional to body fat content. Insulin and leptin secretion and circulating levels are also influenced by recent energy intake and dietary macronutrient content. Insulin and leptin concentrations decrease during fasting and energy-restricted diets, independent of body fat changes, ensuring that feeding is triggered before body energy stores become depleted [42]. In SCA the roles of leptin and insulin in modulating appetite are unclear. Individuals with SCA have lower fat mass (FM) compared to age matched controls [13]. Further, plasma leptin concentration normalized for differences in fat mass have been reported to be lower in patients with SCA compared with controls [43]. Additionally blood glucose levels in response to an oral glucose tolerance test have been reported to be higher [44] and C-peptide to be lower in SCA [45] compared with controls suggesting an impairment of insulin secretion in SCA. On the other hand peripheral insulin sensitivity is similar in SCA and controls [46]. Taken together, the lower leptin concentration and relative insulinopenia represent a physiological signal to stimulate appetite. However it is likely that the chronic inflammation of SCA is associated with increased production of cytokines such as TNF-a and IL6, which inhibit the actions of leptin and insulin both at the level of the hypothalamus and peripherally thereby contributing to the relative hypophagia and wasting observed in SCA. Indeed, IL6 concentrations and other proinflammatory cytokines have been shown to be increased in the steady state in children and adults with SCA [47–50]. In contrast the reduction of inflammation by feeding a high protein diet at weaning in the Berkeley transgenic sickle cell mice model was associated with improved rate of weight gain [51] supporting the theory that the relative hypophagia is due to elevated inflammatory mediators.

4.2 Energy expenditure

The components of total energy expenditure are:

  • • resting energy expenditure (REE) – energy required for basal and post-absorptive metabolism;
  • • thermic effect of food (TEF) – energy to digest and metabolise food;
  • • physical activity energy expenditure (PAEE).

Thus, at balance, and hence weight neutrality, total energy intake (TEI) = REE + TEF + PAEE. In normal adults, REE is the largest component, comprising of 60–80% of TEE, with TEF accounting < 10% of the TEE. Physical activity energy expenditure (PAEE) is the most variable component of TEE contributing 10–30% in fairly sedentary populations [52].

Total energy expenditure and REE have been examined simultaneously in two reports [13,53]. Both reported lower absolute TEE in SCA (13.8 MJ/d versus 10.5 MJ), but differences disappeared after adjustment for fat-free mass (FFM). In children, adolescents and non-wasted adults with SCA, REE is increased even after adjusting for differences in FFM [9,10,13–16]. Although FFM is a better predictor of REE than body weight, it only accounts for 53–88% of the variability in REE because metabolically inactive components are included [54]. In the JSCCS, we have found that FFM accounted for 57% of the variability of REE.

A relative increase in REE/FFM could be due to an increase in the size of the metabolically active components, or increases in the metabolic rate of the individual tissues. In none of the studies reported here [13,53] were the components of FFM measured directly as this is difficult; rather FFM, was either estimated from anthropometry or deuterium dilution. However, the composition of FFM is not constant across the range of body composition [55], and the relative proportions of its metabolically active components namely, muscle mass and organ mass, as well as their hydration are likely to vary as individuals become more wasted [56,57]. Since visceral components of the FFM (liver, heart, kidney, intestine) utilize nearly half of the total oxygen consumption at rest while skeletal muscle, which comprises up to 50% of the body weight, contributes 18–22% of REE [54,58]. Thus an increase in the organ mass: FFM ratio in SCA compared with controls would result in an increase in REE adjusted for FFM.

Increased REE per FFM could also result from an increased energy flux rate through metabolically active tissues [59]. This increased metabolic flux may be driven by the high rates of red cell turnover as a result of chronic haemolysis [7], increased cardiac output [60,61] and protein turnover [9,10,12,14,62,63] that occurs in sickle cell anaemia. The contribution of glucose turnover and lipid metabolism to the hypermetabolism of SCA is unclear. In other models of hypermetabolism and wasting such as cancer cachexia increased glucose turnover and altered lipid metabolism play a role in the associated hypermetabolism [64].

In the two studies in which TEE and REE were measured simultaneously [13,53], physical activity was not directly measured but was computed as the difference between TEE and REE. This is technically incorrect as this assumes that TEF is constant and similar in magnitude between individuals with SCA and controls. Nevertheless, the calculated PAEE from these two studies was reportedly lower in children with SCA compared to controls, suggesting that they had adapted to their level of energy intake by limiting physical work [13,53].

Diet induced thermogenesis contributes the least quantitatively to TEE. However, in chronic energy deficient adults TEF is increased and this is associated with substrate oxidation rates suggestive of the predominant utilization of carbohydrate as fuel both in the fasted and the fed states [65]. If the metabolic adaptation of the wasted individual with SCA is comparable to wasting associated with chronic energy deficient adults then TEF would be expected to increase also.

5 Summary

In summary, I have argued that the wasting in SCA is due to multiple causes including:

  • • inappropriately low energy intake due to appetite suppression by inflammatory mediators;
  • • elevated energy expenditure related to:
    • ∘ physiological adaptations to haemolysis,
    • ∘ changes in body composition resulting in a relative increase in visceral FFM,
    • ∘ inflammation.

The metabolic adaptation to mismatch between energy intake and demand is complex and undoubtedly involves changes in body composition and a repartitioning of the components of energy expenditure. The adaptive response will be dependent upon prior nutritional status, the magnitude of the mismatch, and the duration of exposure to the mismatch. The studies to date have failed to fully elucidate the physiological adaptations in individuals with SCA especially in the wasted adult with SCA. The importance of understanding the mechanism of wasting resides in the observation that wasting, a marker of negative energy balance, is associated with poor clinical outcome. Because the wasting of SCA shares the functional impairments noted in other high metabolic demand chronic disease states complicated by wasting, then improvement of nutritional status by reducing the degree of wasting, holds the potential for ameliorating the course of sickle cell anaemia.

Disclosure of interest

The author declares that he has no conflicts of interest concerning this article.


References

[1] M. Wiseman; A.A. Jackson Nutrition in health and disease, Clin. Med., Volume 4 (2004) no. 5, pp. 397-400

[2] D.I. Phillips; S.G. Matthews Is perinatal neuroendocrine programming involved in the developmental origins of metabolic disorders?, World J. Diabetes, Volume 2 (2011) no. 12, pp. 211-216

[3] J.E. Blundell; P. Caudwell; C. Gibbons; M. Hopkins; E. Naslund; N. King et al. Role of resting metabolic rate and energy expenditure in hunger and appetite control: a new formulation, Dis. Model Mech., Volume 5 (2012) no. 5, pp. 608-613

[4] J.A. Levine Measurement of energy expenditure, Public Health Nutr., Volume 8 (2005) no. 7A, pp. 1123-1132

[5] P. Shetty Energy requirements of adults, Public Health Nutr., Volume 8 (2005) no. 7A, pp. 994-1009

[6] D.C. Rees; T.N. Williams; M.T. Gladwin Sickle cell disease, Lancet, Volume 376 (2010) no. 9757, pp. 2018-2031

[7] C.T. Noguchi; A.N. Schechter; G.P. Rodgers Sickle cell disease pathophysiology, Baillieres Clin. Haematol., Volume 6 (1993) no. 1, pp. 57-91

[8] M. Reid; A. Badaloo; T. Forrester; F. Jahoor In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease, Am. J. Physiol. Endocrinol. Metab., Volume 291 (2006) no. 1, p. E73-E79

[9] A. Badaloo; A.A. Jackson; F. Jahoor Whole body protein turnover and resting metabolic rate in homozygous sickle cell disease, Clin. Sci., Volume 77 (1989), pp. 93-97

[10] M.J. Borel; M.S. Buchowski; E.A. Turner; R.E. Goldstein; P.J. Flakoll Protein turnover and energy expenditure increase during exogenous nutrient availability in sickle cell disease, Am. J. Clin. Nutr., Volume 68 (1998) no. 3, pp. 607-614

[11] M.J. Borel; M.S. Buchowski; E.A. Turner; B.B. Peeler; R.E. Goldstein; P.J. Flakoll Alterations in basal nutrient metabolism increase resting energy expenditure in sickle cell disease, Am. J. Physiol., Volume 274 (1998) no. 2 Pt 1, p. E357-E364

[12] A. Badaloo; A. Emond; S. Venugopal; G. Serjeant; A.A. Jackson The effect of splenectomy on whole body protein turnover in homozygous sickle cell disease, Acta Paediatr. Scand., Volume 80 (1991), pp. 103-105

[13] E.M. Barden; B.S. Zemel; D.A. Kawchak; M.I. Goran; K. Ohene-Frempong; V.A. Stallings Total and resting energy expenditure in children with sickle cell disease, J. Pediatr., Volume 136 (2000) no. 1, pp. 73-79

[14] M.S. Buchowski; F.A. de la Fuente; P.J. Flakoll; K.Y. Chen; E.A. Turner Increased bone turnover is associated with protein and energy metabolism in adolescents with sickle cell anemia, Am. J. Physiol. Endocrinol. Metab., Volume 280 (2001) no. 3, p. E518-E527

[15] A. Singhal; P. Davies; A. Sahota; P.W. Thomas; G.R. Serjeant Resting metabolic rate in homozygous sickle cell disease, Am. J. Clin. Nutr., Volume 57 (1993) no. 1, pp. 32-34

[16] A. Singhal; S. Parker; L. Linsell; G. Serjeant Energy intake and resting metabolic rate in preschool Jamaican children with homozygous sickle cell disease, Am. J. Clin. Nutr., Volume 75 (2002) no. 6, pp. 1093-1097

[17] K.J. Sullivan; N. Kissoon; E. Sandler; C. Gauger; M. Froyen; L. Duckworth et al. Effect of oral arginine supplementation on exhaled nitric oxide concentration in sickle cell anemia and acute chest syndrome, J. Pediatr. Hematol. Oncol., Volume 32 (2010) no. 7, p. e249-e258

[18] M.S. Kramer; Y. Rooks; L.A. Washington; H.A. Pearson Pre- and postnatal growth and development in sickle cell anemia, J Pediatr, Volume 96 (1980) no. 5, pp. 857-860

[19] H.I. Hyacinth; B.E. Gee; J.M. Hibbert The role of nutrition in sickle cell disease, Nutr. Metab. Insights, Volume 3 (2010), pp. 57-67

[20] A.W. Al-Saqladi; R. Cipolotti; K. Fijnvandraat; B.J. Brabin Growth and nutritional status of children with homozygous sickle cell disease, Ann. Trop. Paediatr., Volume 28 (2008) no. 3, pp. 165-189

[21] M.T. Ashcroft; G.R. Serjeant Body habirus of Jamaican adults with sickle cell anemia, South Med. J., Volume 65 (1972) no. 5, pp. 579-582

[22] R. Cipolotti; M.F. Caskey; R.P. Franco; E.V. Mello; A.L. Dal Fabbro; R.Q. Gurgel et al. Childhood and adolescent growth of patients with sickle cell disease in Aracaju, Sergipe, north-east Brazil, Ann. Trop. Paediatr., Volume 20 (2000) no. 2, pp. 109-113

[23] B.S. Zemel; D.A. Kawchak; K. Ohene-Frempong; J.I. Schall; V.A. Stallings Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease, Pediatr. Res., Volume 61 (2007) no. 5 Pt 1, pp. 607-613

[24] A.W. Al-Saqladi; H.A. Bin-Gadeen; B.J. Brabin Growth in children and adolescents with sickle cell disease in Yemen, Ann. Trop. Paediatr., Volume 30 (2010) no. 4, pp. 287-298

[25] P.W. Thomas; A. Singhal; M. Hemmings-Kelly; G.R. Serjeant Height and weight reference curves for homozygous sickle cell disease, Arch. Dis. Child., Volume 82 (2000) no. 3, pp. 204-208

[26] M.C. Stevens; G.H. Maude; L. Cupidore; H. Jackson; R.J. Hayes; G.R. Serjeant Prepubertal growth and skeletal maturation in children with sickle cell disease, Pediatrics, Volume 78 (1986) no. 1, pp. 124-132

[27] C. Prudhon; A. Briend; D. Laurier; M.H. Golden; J.Y. Mary Comparison of weight- and height-based indices for assessing the risk of death in severely malnourished children, Am. J. Epidemiol., Volume 144 (1996) no. 2, pp. 116-123

[28] R. Sharma; V.G. Florea; A.P. Bolger; W. Doehner; N.D. Florea; A.J. Coats et al. Wasting as an independent predictor of mortality in patients with cystic fibrosis, Thorax, Volume 56 (2001) no. 10, pp. 746-750

[29] K. Kalantar-Zadeh; T.B. Horwich; A. Oreopoulos; C.P. Kovesdy; H. Younessi; S.D. Anker et al. Risk factor paradox in wasting diseases, Curr. Opin. Clin. Nutr. Metab. Care, Volume 10 (2007) no. 4, pp. 433-442

[30] S.T. Miller; L.A. Sleeper; C.H. Pegelow; L.E. Enos; W.C. Wang; S.J. Weiner et al. Prediction of adverse outcomes in children with sickle cell disease, N. Engl. J. Med., Volume 342 (2000) no. 2, pp. 83-89

[31] C.T. Quinn; N.J. Lee; E.P. Shull; N. Ahmad; Z.R. Rogers; G.R. Buchanan Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort, Blood, Volume 111 (2008) no. 2, pp. 544-548

[32] S.E. Cox; J. Makani; A.J. Fulford; A.N. Komba; D. Soka; T.N. Williams et al. Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania, Haematologica, Volume 96 (2011) no. 7, pp. 948-953

[33] M. Jackson; S. Walker; T. Forrester; J.K. Cruickshank; R. Wilks Social and dietary determinants of body mass index of adult Jamaicans of African origin, Eur. J. Clin. Nutr., Volume 57 (2003) no. 4, pp. 621-627

[34] A.C. Finan; M.A. Elmer; S.R. Sasanow; S. McKinney; M.O. Russell; F.M. Gill Nutritional factors and growth in children with sickle cell disease, Am. J. Dis. Child, Volume 142 (1988) no. 2, pp. 237-240

[35] O. Modebe; S.A. Ifenu Growth retardation in homozygous sickle cell disease: role of calorie intake and possible gender-related differences, Am. J. Hematol., Volume 44 (1993) no. 3, pp. 149-154

[36] F.M. Gill; L.A. Sleeper; S.J. Weiner; A.K. Brown; R. Bellevue; R. Grover et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease, Blood, Volume 86 (1995) no. 2, pp. 776-783

[37] M.B. Heyman; E. Vichinsky; R. Katz; B. Gaffield; D. Hurst; R. Castillo et al. Growth retardation in sickle cell disease treated by nutritional support, Lancet, Volume 1 (1985) no. 8434, pp. 903-906

[38] S. Collins; M. Myatt; B. Golden Dietary treatment of severe malnutrition in adults, Am. J. Clin. Nutr., Volume 68 (1998) no. 1, pp. 193-199

[39] P.J. Havel Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis, Exp. Biol. Med. (Maywood), Volume 226 (2001) no. 11, pp. 963-977

[40] J.E. Blevins; D.G. Baskin Hypothalamic-brainstem circuits controlling eating, Forum. Nutr., Volume 63 (2010), pp. 133-140

[41] S. French Effects of dietary fat and carbohydrate on appetite vary depending upon site and structure, Br. J. Nutr., Volume 92 (2004) no. Suppl. 1, p. S23-S26

[42] P.J. Havel Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin, Curr. Opin. Lipidol., Volume 13 (2002) no. 1, pp. 51-59

[43] M.S. Buchowski; L.A. Simmons; K.Y. Chen; P.J. Flakoll; B.G. Mellen; E.A. Turner Plasma leptin association with body composition and energy expenditure in sickle cell disease, J. Am. Coll. Nutr., Volume 19 (2000) no. 2, pp. 228-236

[44] A.D. Adekile; S.O. Olusi; D.D. Oyebola Oral glucose tolerance test in children with sickle cell anaemia, East Afr. Med. J., Volume 62 (1985) no. 3, pp. 213-217

[45] S.T. Saad; G.S. Braga; M.J. Saad Decreased C-peptide secretion in sickle cell anemia, Acta Haematol., Volume 82 (1989) no. 2, pp. 81-84

[46] J.C. ter Maaten; E.H. Serne; S.J. Bakker; W.S. van Eps; A.J. Donker; R.O. Gans Effects of insulin on glucose uptake and leg blood flow in patients with sickle cell disease and normal subjects, Metabolism, Volume 50 (2001) no. 4, pp. 387-392

[47] S.C. Taylor; S.J. Shacks; R.A. Mitchell; A. Banks Serum interleukin-6 levels in the steady state of sickle cell disease, J. Interferon. Cytokine Res., Volume 15 (1995) no. 12, pp. 1061-1064

[48] S.C. Taylor; S.J. Shacks; Z. Qu; P. Wiley Type 2 cytokine serum levels in healthy sickle cell disease patients, J. Natl. Med. Assoc., Volume 89 (1997) no. 11, pp. 753-757

[49] K.L. Bourantas; G.N. Dalekos; A. Makis; A. Chaidos; S. Tsiara; A. Mavridis Acute phase proteins and interleukins in steady state sickle cell disease, Eur. J. Haematol., Volume 61 (1998) no. 1, pp. 49-54

[50] J.M. Hibbert; L.L. Hsu; S.J. Bhathena; I. Irune; B. Sarfo; M.S. Creary et al. Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease, Exp. Biol. Med. (Maywood), Volume 230 (2005) no. 1, pp. 68-74

[51] D.R. Archer; J.K. Stiles; G.W. Newman; A. Quarshie; L.L. Hsu; P. Sayavongsa et al. C-reactive protein and interleukin-6 are decreased in transgenic sickle cell mice fed a high protein diet, J. Nutr., Volume 138 (2008) no. 6, pp. 1148-1152

[52] E. Ravussin; S. Lillioja; T.E. Anderson; L. Christin; C. Bogardus Determinants of 24-hour energy expenditure in man. Methods and results using a respiratory chamber, J. Clin. Invest., Volume 78 (1986) no. 6, pp. 1568-1578

[53] A. Singhal; P. Davies; K.J. Wierenga; P. Thomas; G. Serjeant Is there an energy deficiency in homozygous sickle cell disease?, Am. J. Clin. Nutr., Volume 66 (1997) no. 2, pp. 386-390

[54] K.M. Nelson; R.L. Weinsier; C.L. Long; Y. Schutz Prediction of resting energy expenditure from fat-free mass and fat mass, Am. J. Clin. Nutr., Volume 56 (1992) no. 5, pp. 848-856

[55] Z. Wang; P. Deurenberg; W. Wang; A. Pietrobelli; R.N. Baumgartner; S.B. Heymsfield Hydration of fat-free body mass: review and critique of a classic body composition constant, Am. J. Clin. Nutr., Volume 69 (1999) no. 5, pp. 833-841

[56] M.J. Soares; L.S. Piers; P.S. Shetty; S. Robinson; A.A. Jackson; J.C. Waterlow Basal metabolic rate, body composition and whole body protein turnover in Indian men with differing nutritional status, Clin. Sci. (Colch), Volume 81 (1991) no. 3, pp. 419-425

[57] L. Garby; O. Lammert An explanation for the non-linearity of the relation between energy expenditure and fat-free mass, Eur. J. Clin. Nutr., Volume 46 (1992) no. 3, pp. 235-236

[58] D. Gallagher; D. Belmonte; P. Deurenberg; Z. Wang; N. Krasnow; F.X. Pi-Sunyer et al. Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass, Am. J. Physiol., Volume 275 (1998) no. 2 Pt 1, p. E249-E258

[59] K. Illner; G. Brinkmann; M. Heller; A. Bosy-Westphal; M.J. Muller Metabolically active components of fat-free mass and resting energy expenditure in nonobese adults, Am. J. Physiol. Endocrinol. Metab., Volume 278 (2000) no. 2, p. E308-E315

[60] B.S. Denenberg; G. Criner; R. Jones; J.F. Spann Cardiac function in sickle cell anemia, Am. J. Cardiol., Volume 51 (1983) no. 10, pp. 1674-1678

[61] J.M. Hibbert; M.S. Creary; B.E. Gee; I.D. Buchanan; A. Quarshie; L.L. Hsu Erythropoiesis and myocardial energy requirements contribute to the hypermetabolism of childhood sickle cell anemia, J. Pediatr. Gastroenterol. Nutr., Volume 43 (2006) no. 5, pp. 680-687

[62] A.V. Badaloo; A. Singhal; T.E. Forrester; G.R. Serjeant; A.A. Jackson The effect of splenectomy for hypersplenism on whole body protein turnover, resting metabolic rate and growth in sickle cell disease, Eur. J. Clin. Nutr., Volume 50 (1996), pp. 672-675

[63] E.K. Salman; M.W. Haymond; E. Bayne; B.K. Sager; A. Wiisanen; P. Pitel et al. Protein and energy metabolism in prepubertal children with sickle cell anemia, Pediatr. Res., Volume 40 (1996) no. 1, pp. 34-40

[64] M.D. Barber The pathophysiology and treatment of cancer cachexia, Nutr. Clin. Pract., Volume 17 (2002) no. 4, pp. 203-209

[65] L.S. Piers; M.J. Soares; P.S. Shetty Thermic effect of a meal. 2. Role in chronic undernutrition, Br. J. Nutr., Volume 67 (1992) no. 2, pp. 177-185


Comments - Policy